Trial · NCT04187404
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Cohort 2A (Non-randomized) | 26 | |
| Overall Study | STARTED | Randomized Extension of Cohort 2A (3 Arms): C2A-I | 13 | |
| Overall Study | STARTED | Randomized Extension of Cohort 2A (3 Arms): C2A-II | 2 | |
| Overall Study | STARTED | Randomized Extension of Cohort 2A (3 Arms): C2A-III | 4 | |
| Overall Study | STARTED | Cohort 2B (Non-randomized) | 7 | |
| Overall Study | STARTED | Cohort 3A (Non-randomized) | 13 | |
| Overall Study | STARTED | Cohort 3B (Non-randomized) | 5 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Cohort 2A (Non-randomized) | 2 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Randomized Extension of Cohort 2A (3 Arms): C2A-I | 0 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Randomized Extension of Cohort 2A (3 Arms): C2A-II | 0 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Randomized Extension of Cohort 2A (3 Arms): C2A-III | 0 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Cohort 2B (Non-randomized) | 0 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Cohort 3A (Non-randomized) | 1 | |
| Overall Study | Started and Originally Enrolled in Cohort 1 (Safety lead-in). | Cohort 3B (Non-randomized) | 0 | |
| Overall Study | COMPLETED | Cohort 2A (Non-randomized) | 26 | |
| Overall Study | COMPLETED | Randomized Extension of Cohort 2A (3 Arms): C2A-I | 13 | |
| Overall Study | COMPLETED | Randomized Extension of Cohort 2A (3 Arms): C2A-II | 2 | |
| Overall Study | COMPLETED | Randomized Extension of Cohort 2A (3 Arms): C2A-III | 4 | |
| Overall Study | COMPLETED | Cohort 2B (Non-randomized) | 7 | |
| Overall Study | COMPLETED | Cohort 3A (Non-randomized) | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04187404/flow